advertisement
Zebardast N 12
Showing records 1 to 12 | Display all abstracts from Zebardast N92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Yang SA
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Zebardast N; Sekimitsu S
Ophthalmology 2021; 0:
92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Mitchell W; Hall N
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Wang J; Elze T
Ophthalmology 2021; 0:
92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Elze T; Lorch AC
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Gharahkhani P
Ophthalmology 2021; 0:
92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Miller JW
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Cole BS
Ophthalmology 2021; 0:
92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Zebardast N
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Lin MM; Segrè AV
Ophthalmology 2021; 0:
92062 Trends and Usage Patterns of Minimally Invasive Glaucoma Surgery in the United States: IRIS® Registry Analysis 2013-2018
Ophthalmology. Glaucoma 2021; 0:
92116 Characteristics of Gln368Ter Myocilin Variant and Influence of Polygenic Risk on Glaucoma Penetrance in the UK Biobank
Segrè AV; Wiggs JL;
Ophthalmology 2021; 0:
